Latest News

STAT Plus: Pharmalittle: AbbVie accused of sweeping Humira scheme; pharma dodging taxes in the developing world

Good morning, everyone. Damian Garde here, filling in for Ed Silverman as the working week tilts toward almost over. The sun has crept into view after a sodden Tuesday, which will hopefully brighten your routine of meetings, deadlines, and requisite office small talk. To get you started, please find a few items of interest. And, as always, if you hear anything interesting, do let us know.

AbbVie (ABBV) is accused of using old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira, STAT tells us. According to a lawsuit filed by the California insurance commissioner, AbbVie hired registered nurses to act as “ambassadors” to visit patients at home and help with administering the drug, but instead were used to ensure that prescriptions were continually refilled.

Continue to STAT Plus to read the full story…

Source link

Related posts

Stem cells show promise as drug delivery tool for childhood brain cancer


California bill would fight deals that delay generic drugs


Opinion: Medical students can help combat Covid-19. Don’t send them home


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy